Raju Prasad
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 24SEC | CRSPCRISPR Therapeutics AG | Sell | 3,70815,565 held (−19%) | $46.78 | $173K | +14.1% |
| Mar 17SEC | CRSPCRISPR Therapeutics AG | Sell | 5,84817,794 held (−25%) | $48.26 | $282K | +10.6% |
| Mar 17SEC | CRSPCRISPR Therapeutics AG | Sell | 4,02113,773 held (−23%) | $48.26 | $194K | +10.6% |
| Jan 26SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 34,9726,767 held (−84%) | $60.19 | $2.1M | -11.3% |
| Jan 8SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 18,93317,534 held (−52%) | $60.18 | $1.1M | -11.3% |
| Jan 8SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 5,00412,530 held (−29%) | $60.00 | $300K | -11.0% |
| Jan 8SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 5,7636,767 held (−46%) | $60.21 | $347K | -11.3% |
| Dec 23SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 3,52813,239 held (−21%) | $55.10 | $194K | -3.1% |
| Dec 23SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 5,4727,767 held (−41%) | $56.33 | $308K | -5.2% |
| Dec 23SEC | CRSPCRISPR Therapeutics AG | Sell Plan | 1,0006,767 held (−13%) | $56.89 | $57K | -6.2% |
- Sell
CFO Raju Prasad sold $2.1M of CRSP at $60.19 — cuts the stake by 84%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Raju Prasad sold $1.1M of CRSP at $60.18 — cuts the stake by 52%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Raju Prasad sold $300K of CRSP at $60.00 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Raju Prasad sold $347K of CRSP at $60.21 — cuts the stake by 46%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Raju Prasad sold $194K of CRSP at $55.10 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Raju Prasad sold $308K of CRSP at $56.33 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.